APGE news · APGE stock

AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?

Yahoo Finance · Aug 29, 2026 · Apogee Therapeutics, Inc. Common Stock (APGE)

Eli Lilly's metabolic therapies drove 45% revenue growth, but its valuation premium demands scrutiny against AbbVie's defensive dividend appeal.

Original at Yahoo Finance

Not investment advice. Cached headline, not a full reprint.